Related references
Note: Only part of the references are listed.Meta-Analysis of Bioprosthetic Valve Thrombosis After Transcatheter Aortic Valve Implantation
Tobias Rheude et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding
Lindsey R. Mitrani et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2021)
The use of direct oral anticoagulants in patients with ventricular assist devices: Is there hope for Factor Xa inhibition?
Thomas Meredith et al.
ARTIFICIAL ORGANS (2021)
Association Between Anticoagulation and Survival in Interstitial Lung Disease An Analysis of the Pulmonary Fibrosis Foundation Patient Registry
Christopher S. King et al.
CHEST (2021)
Plasma D-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trial
Joao Pedro Ferreira et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Anticoagulation for stroke prevention in patients with hypertrophic cardiomyopathy and atrial fi brillation: A review
M. Farhan Nasser et al.
HEART RHYTHM (2021)
Left ventricular thrombus on cardiovascular magnetic resonance imaging in non-ischaemic cardiomyopathy
Matthew Hooks et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2021)
ERS statement on chronic thromboembolic pulmonary hypertension
Marion Delcroix et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
Hossein-Ardeschir Ghofrani et al.
RESPIRATORY MEDICINE (2021)
Thromboembolism in Heart Failure Patients in Sinus Rhythm Epidemiology, Pathophysiology, Clinical Trials, and Future Direction
Andrew Y. Lin et al.
JACC-HEART FAILURE (2021)
Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension
Mateo Porres-Aguilar et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry Enrollment Characteristics and 1-Year Follow-up
Kim M. Kerr et al.
CHEST (2021)
Plasma D-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trial
Joao Pedro Ferreira et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
In vitro assessment of P-gp and BCRP transporter-mediated drug-drug interactions of riociguat with direct oral anticoagulants
Elodie Jacqueroux et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2020)
A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension
Katherine Bunclark et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
Ole De Backer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
George D. Dangas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart Disease
Meredith L. Hampton et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2020)
Use of direct oral anticoagulants after heart transplantation
Erik J. Henricksen et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention An Updated Network Meta-analysis
Renato D. Lopes et al.
JAMA CARDIOLOGY (2020)
Antithrombotic Therapy for Patients With Left Ventricular Mural Thrombus
Benoit Lattuca et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study
Philipp Blanke et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi
Austin A. Robinson et al.
JAMA CARDIOLOGY (2020)
Ablation of Atrial Fibrillation Without Left Atrial Appendage Imaging in Patients Treated With Direct Oral Anticoagulants
Mohamed Diab et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)
Leaflet immobility and thrombosis in transcatheter aortic valve replacement
Arnold C. T. Ng et al.
EUROPEAN HEART JOURNAL (2020)
Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population The COOL-AF Registry
Rungroj Krittayaphong et al.
STROKE (2020)
Direct Oral Anticoagulant Versus Warfarin for Watchman Left Atrial Appendage Occlusion-Systematic Review
Jalaj Garg et al.
JACC-CLINICAL ELECTROPHYSIOLOGY (2020)
Real-life data of direct anticoagulant use, bleeding risk and venous thromboembolism recurrence in chronic thromboembolic pulmonary hypertension patients: an observational retrospective study
Sert Sena et al.
PULMONARY CIRCULATION (2020)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Craig T. January et al.
CIRCULATION (2019)
Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
Patricia O. Guimaraes et al.
CLINICAL CARDIOLOGY (2019)
Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis
Ju Youn Kim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D. Lopes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Real-world assessment of off-label direct oral anticoagulant dosing for venous thromboembolism
John A. Saunders et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)
Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation
Wen-Han Cheng et al.
STROKE (2019)
Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy
Edwin Lam et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials
George Ntaios et al.
INTERNATIONAL JOURNAL OF STROKE (2019)
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
Pascal Vranckx et al.
LANCET (2019)
Use of direct oral anticoagulants prevents increase in pulmonary vascular resistance and incidence of clinical worsening in patients with chronic thromboembolic pulmonary hypertension
Kazuya Hosokawa et al.
THROMBOSIS RESEARCH (2019)
Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
Luis Alberto Garcia Rodriguez et al.
BMJ OPEN (2019)
Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation
So-Ryoung Lee et al.
YONSEI MEDICAL JOURNAL (2019)
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Vittorio Pengo et al.
BLOOD (2018)
Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany
Thorsten Kramm et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease
Dragos Vinereanu et al.
HEART (2018)
In Vitro Assessment of Pharmacokinetic Drug-Drug Interactions of Direct Oral Anticoagulants: Type 5-Phosphodiesterase Inhibitors Are Inhibitors of Rivaroxaban and Apixaban Efflux by P-Glycoprotein
Victor Margelidon-Cozzolino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Daily 10 mg rivaroxaban as a therapy for ventricular thrombus related to left ventricular non-compaction cardiomyopathy A case report
Huan Sun et al.
MEDICINE (2018)
A review of the use of direct oral anticoagulant use in orthotopic heart transplantation recipients
Rosaleen Boswell et al.
TRANSPLANTATION REVIEWS (2018)
Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided
Andrea Huppertz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke
E. Mara Vollema et al.
EUROPEAN HEART JOURNAL (2017)
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial
Raffaele De Caterina et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Assessment of the quality of anticoagulation management in patients with pulmonary arterial hypertension
Tamara Roldan et al.
THROMBOSIS RESEARCH (2017)
Incidence, Predictors, and Mid-Term Outcomes of Possible Leaflet Thrombosis After TAVR
Ryo Yanagisawa et al.
JACC-CARDIOVASCULAR IMAGING (2017)
Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial
Martin Andreas et al.
CIRCULATION-HEART FAILURE (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes The ORBIT-AF II Registry
Benjamin A. Steinberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
C. Michael Gibson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension
Laurence Gabriel et al.
RESPIRATION (2016)
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol
Alicia Calderone et al.
BMJ OPEN (2016)
Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure A Meta-Analysis
Gianluigi Savarese et al.
JACC-HEART FAILURE (2016)
Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)
Ioana R. Preston et al.
CIRCULATION (2015)
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Alvaro Avezum et al.
CIRCULATION (2015)
Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial
Faiez Zannad et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Anticoagulation and Survival in Pulmonary Arterial Hypertension Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
Karen M. Olsson et al.
CIRCULATION (2014)
Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
Gunter Breithardt et al.
EUROPEAN HEART JOURNAL (2014)
Embolic strokes of undetermined source: the case for a new clinical construct
Robert G. Hart et al.
LANCET NEUROLOGY (2014)
Stroke in Heart Failure in Sinus Rhythm: The Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction Trial
Patrick M. Pullicino et al.
CEREBROVASCULAR DISEASES (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
CIRCULATION (2013)
Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
Mohamed Bassiouny et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2013)
Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus Rhythm A Subgroup Analysis of WARCEF, a Randomized Controlled Trial
Shunichi Homma et al.
CIRCULATION-HEART FAILURE (2013)
Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension
Ivo R. Henkens et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
Imre Noth et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Antiinflammatory and Antifibrotic Effects of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in a Murine Model of Interstitial Lung Disease
Galina S. Bogatkevich et al.
ARTHRITIS AND RHEUMATISM (2011)
A role for coagulation factor Xa in experimental pulmonary arterial hypertension
Martina Delbeck et al.
CARDIOVASCULAR RESEARCH (2011)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Results From an International Prospective Registry
Joanna Pepke-Zaba et al.
CIRCULATION (2011)
Anticoagulant therapy for idiopathic pulmonary fibrosis
H Kubo et al.
CHEST (2005)
Share Paper
